Resistance to combination drugs threatens efforts to eradicate malaria

June 19, 2013, CORDIS
Resistance to combination drugs threatens efforts to eradicate malaria
Credit: Shutterstock

With 300-500 million people falling ill to malaria each year, this debilitating tropical disease remains a global problem. Current combination drug therapy is still generally effective, but recent signs of resistance present scientists with a new challenge.

Malaria is major issue in Africa, in particular, where drug resistance in the 1990s contributed to a higher than usual death rate from the disease. However, Dr Henk Schallig from the Royal Tropical Institute in the Netherlands is hopeful this can be prevented from happening again.

This comes as results are emerging from the five-year MALACTRES project. Research has focused on multi-drug resistance in malaria under artemisinin-based (ACT). The research team has assessed specific genetic markers and worked on innovative, rapid and simple diagnostics.

Dr Schallig explains: 'Many drugs to treat malaria are deemed to be ineffective, particularly in rural Africa. So there has been an urgent need for more affordable, safe and effective treatment alternatives. ACT is currently the mainstay of therapy. It is efficacious, but at risk due to emerging resistance. This is why we have developed sensitive tools for the prompt detection of malaria, and to tackle the growing resistance of parasites to existing anti-.'

The project has been able to investigate the existence of specific associated with increased parasite transmission after treatment. Clinical trials have been supported by seven institutes across Europe and Africa which have helped to improve the diagnosis and treatment of malaria. They recently conducted ACT trials in Kenya and and assessed the impact of various genes on parasite prevalence, longevity and transmission.

The MALACTRES research consortium has also developed molecular diagnostic assays based on (PCR). PCR is a relatively cost-effective and simple method to quickly diagnose diseases, identify bacteria and viruses and carry out other forms of genetic identification. In this case it was used to detect all known parasite species directly from the blood of potentially infected individuals, via field tests in Nigeria and Kenya. Tests have also been developed to identify and diagnose the presence of resistant malaria parasite strains, in particular Plasmodium falciparum.

Clinical studies have been a major part of this project, although Dr Schallig points out that there have been some challenges along the way: 'Climate change has delayed our studies, as in the case of Africa where changing weather patterns are affecting the rainy seasons, which makes it harder to predict when the transmission of malaria may occur. Now it is difficult to predict transmission patterns and people in East Africa are starting to complain that it is now too cold!'

Despite this complication, the MALACTRES study will significantly contribute to the long-term fight against malaria by providing invaluable insight into candidate implicated in the process. Although the project is due to end in the summer, the project team is hopeful of carrying on with their research using the knowledge already gained to continue the fight to eradicate .

Dr Schallig says he is keen to keep the MALACTRES 'brand' going. The project aims to secure further funding to ensure that the tests become readily available and to further study the background of ACT . 'The consortium is also committed to publishing our research findings, and a number of high-profile publications will appear once the project ends,' he concludes.

Explore further: Drug resistance may make malaria parasites vulnerable to other substances

More information: MALACTRES www.malactres.eu

Related Stories

Drug resistance may make malaria parasites vulnerable to other substances

June 4, 2013
Malaria parasites that develop resistance to the most effective class of anti-malarial drugs may become susceptible to other treatments as a result. The discovery could reveal potential new drug options, which would be essential ...

Gene clues point to Cambodia for resistant malaria

April 28, 2013
Gene analysis of malaria parasites has pinpointed western Cambodia as the hotspot of strains that are dangerously resistant to artesiminin, the frontline drug against the disease, scientists said on Sunday.

Study finds early signs of malaria drug resistance in Africa

April 27, 2012
Africa's deadliest malaria parasite has shown resistance in lab tests to one of the most powerful drugs on the market -- a warning of possible resistance to follow in patients, scientists said Friday.

New malaria test kit gives a boost to elimination efforts worldwide

May 17, 2013
A new, highly sensitive blood test that quickly detects even the lowest levels of malaria parasites in the body could make a dramatic difference in efforts to tackle the disease in the UK and across the world, according to ...

New malaria drug requires just one dose and appears twice as effective as existing regimen

October 17, 2012
Scientists are reporting development of a new malaria drug that, in laboratory tests, has been twice as effective as the best current medicine against this global scourge and may fight off the disease with one dose, instead ...

Malaria's severity reset by mosquito

May 30, 2013
(Medical Xpress)—For the first time, researchers have proven that the way in which malaria is transmitted to the host affects how severe the resulting infection will be.

Recommended for you

A new theory on reducing cardiovascular disease risk in binge drinkers

January 23, 2018
A new study shows that binge drinkers have increased levels of a biomarker molecule—microRNA-21—that may contribute to poor vascular function.

Flu infection study increases understanding of natural immunity

January 23, 2018
People with higher levels of antibodies against the stem portion of the influenza virus hemagglutinin (HA) protein have less viral shedding when they get the flu, but do not have fewer or less severe signs of illness, according ...

New long-acting approach for malaria therapy developed

January 22, 2018
A new study, published in Nature Communications, conducted by the University of Liverpool and the Johns Hopkins University School of Medicine highlights a new 'long acting' medicine for the prevention of malaria.

Virus shown to be likely cause of mystery polio-like illness

January 22, 2018
A major review by UNSW researchers has identified strong evidence that a virus called Enterovirus D68 is the cause of a mystery polio-like illness that has paralysed children in the US, Canada and Europe.

Creation of synthetic horsepox virus could lead to more effective smallpox vaccine

January 19, 2018
UAlberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox. The discovery demonstrates how techniques based on the use of synthetic DNA can be used to ...

Study ends debate over role of steroids in treating septic shock

January 19, 2018
The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.